Washington, D.C.  20549


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  December 13, 2011 (December 13, 2011)

BioDrain Medical, Inc.
(Exact name of Registrant as Specified in its Charter)

(State or Other Jurisdiction of Incorporation)

(Commission File Number)
(IRS Employer Identification No.)
2060 Centre Pointe Boulevard, Suite 7
Mendota Heights, Minnesota 55120
(Address of Principal Executive Offices and Zip Code)

(651) 389-4800
(651) 389-4800
(Registrant’s telephone number, including area code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a)          Departure of Officer or Director

Effective December 7, 2011, Chad A. Ruwe departed as Chief Operating Officer of BioDrain Medical, Inc. Mr. Ruwe remains as a member of the Registrant Board of Directors.  Mr. Ruwe has no disagreement with management or the directors of the Registrant and is supportive of its plans for growth.

(b)          Appointment of Officer or Director

Effective December 12, 2011, Dave Johnson commenced consulting activities relating to the Chief Operating Officer function of BioDrain Medical, Inc.  Dave has over 30 years experience in executive, operations and management positions in rapid growth medical device organizations, directing growth domestically and internationally with products ranging from consumer based disposable commodity items to class III implantable devices.    His experience includes executive management, training, product development, business development, regulatory and quality assurance, operations, supplier development and technology acquisitions.  Prior to BioDrain Medical, Dave was a medical device consultant, President & CEO of Spring Forest Qigong, co-founder and VP of Operations at Epitek, Inc., and was a co-founder and President of Timm Medical Technologies. He also held positions including Vice President-Operations/Technology at UroHealth/Imagyn, Vice-President Operations at Dacomed Corporation and various technical, operations and training positions at American Medical Systems and Pfizer Corporation. He also holds a number of patents in the medical device field and the exercise fitness industry.



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 13, 2011
/s/ Kevin R. Davidson
Kevin R. Davidson
Chief Executive Officer,